Background: Populations of depressed persons are typically comprised of individuals with different courses of depression and thus might carry different risks of death. This study aimed to identify different trajectories of depressive symptoms in community-dwelling older adults and study the risk of death across these trajectories. Methods: In the population-based Rotterdam Study, depressive symptoms (Center for Epidemiological Studies-Depression scale) at three examination rounds (1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)) from 3,325 dementia-free participants (mean age 64.6 ± 6.1 years) were used to identify depression trajectories by latent-class trajectory modeling. Mortality rates by trajectory were calculated over a subsequent 13 year period (2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015), that is using 23 years of follow-up data. Results: Five trajectories of depressive symptoms characterized by low (73.4%), decreasing (11.1%), remitting (5.1%), increasing (7.7%), and high (2.7%) depressive symptoms were identified. Compared with persons in the low symptoms trajectory, persons with a trajectory of increasing depressive symptoms (hazard ratio [HR]: 1.21 [95% CI = 1.02, 1.44]) had a higher risk of death, but not those with remitting depressive symptoms, HR: 1.06 (95% CI = 0.85, 1.32). The estimates for the high symptoms trajectory were also suggestive of a higher risk of mortality, HR: 1.20 (95% CI = 0.91, 1.58). Conclusions: Repeated measures of depression can help predict long-term health outcomes in persons with depressive symptoms. Participants with increasing symptoms over time had a higher risk of death than those with low or no depressive symptoms. Transient high depressive symptoms that remitted were not associated with a higher risk compared with those with no symptoms. Our results open avenues for etiological and prognostic research to focus upon risk factors' key to a particular trajectory.
gene-environment interactions, chronic diseases or disability, life events and daily hassles, social disadvantage, personality attributes, and bereavement (2) . In every individual, depressive symptoms follow a unique course dependent upon a combination of such risk and perpetuating factors, which typically interact (5) (6) (7) . In large populations, individuals can be combined into unique groups with distinct trajectories of depressive symptoms' course (8) . For instance, persons with clinically relevant depressive symptoms may experience them transiently and undergo full remission. Other persons may undergo partial remission only. Yet, others may experience several repeated recurrences of symptoms throughout life with intermittent periods of health, whereas a minority may become chronically depressed. However, it remains largely unknown how these different courses of depressive symptoms relate to mortality, as the existing studies mainly focus on prevalent depression or depressive symptoms. There is a considerable literature reporting on the association of depression and excess mortality. In a comprehensive review and meta-analysis, depression was associated with a 50% higher risk of dying. This risk was comparable in community samples and diseased samples, for example, persons with diabetes, cardiovascular, pulmonary disorders, and cancers (3) . Furthermore, specific symptoms of depression such as sadness were associated with ~30% higher risk of dying in community samples (9) . However, a recent longitudinal study also reported that major depression and not subthreshold depression is associated with excess mortality; the risk in the latter being largely explained by health behaviors and comorbidity (10) . Existing studies have not explored different courses of depressive symptoms in a large population-based longitudinal study, although many disease-specific studies exist that have reported the impact of depression on long-term survival (11) . The long-term course of depression remains largely neglected in existing studies, which is an important gap considering the relapsing and remitting nature of depression (12) (13) (14) (15) (16) . This issue can be addressed by utilizing repeated measures of depressive symptoms to study the course of depression, identify different trajectories of depression in a population, and then study the risk of mortality across these trajectories. Such an approach can help unravel high-risk groups and filter out those groups in which depressive symptoms may have little or no effect on long-term health outcomes. Understanding the possibly differential risks associated with the course of depressive symptoms upon mortality and other outcomes opens avenues for efficient preventive and therapeutic strategies.
The aims of this study were to identify the different trajectories of depressive symptoms in community-dwelling older adults using repeated measures of depressive symptoms and determine the risk of mortality across these trajectories. We were especially interested to investigate how the remitting and relapsing course of depressive symptoms relates to mortality, as many persons suffer from depression during their lifetime but revert back to the nondepressed state.
Methods

Setting
This study was embedded in the Rotterdam Study, a large population-based cohort of persons aged ≥55, ongoing since 1990. Follow-up examinations including home interviews and physical exams at a research center take place every 3 to 4 years. In addition, the cohort is continuously monitored for all major events by a highly efficient data linkage system between the study database and the general practitioners (17) . This study was approved by the medical ethics committee according to the Population Study Act, executed by the Ministry of Health of the Netherlands. Written informed consent was obtained from all participants.
Study Population
This study utilized depressive symptoms data of 3,325 dementia-free participants (aged ≥55 included in the Rotterdam Study cohort) at one or more of the three examination rounds between 1993 and 2004 to identify 12 year trajectories of depressive symptoms. Patients with dementia were excluded to ensure reliability of Hospital Anxiety and Depression Scale/Center for Epidemiological Studies-Depression Scale (HADS/CES-D) questionnaires. These participants were followed for mortality from the third examination round (2002) (2003) (2004) Figure S1) . This study design enabled leveraging three assessments of depressive symptoms for a reliable trajectory classification while ensuring a sufficient number of cases during follow-up to calculate hazard ratios for mortality. Survival analyses were performed from the 2002-2004 examination round onward to avoid a possible bias in trajectory classification due to concomitant deaths occurring during the period of depression assessments. This design also facilitated easy interpretation of risks associated with each trajectory.
Assessment of Depressive Symptoms
In the first examination round, we measured depressive symptoms using two different instruments: the validated Dutch version of the CES-D (18) and the HADS-D (19) . In this round, assessment of depressive symptoms was introduced in the study protocol, and as a pilot project, a random half of participants received the CES-D questionnaire, whereas the other half received the HADS-D questionnaire. For all subsequent rounds, only CES-D was used. The CES-D comprises 20 items, each with a possible score of 0-3, and the score ranges from 0-60 (18) . HADS-D comprises seven items, each with a possible score of 0-3, and the score ranges from 0-21 (19) . Both scales are valid and reliable instruments for assessment of depression and can indicate clinically relevant depressive symptoms. We checked for evidence whether this introduces information bias but we found the same percentage of screen positives (10%) using validated, predefined cutoffs (20) . For analyses, depressive symptom scores were used as a standardized variable, calculated as weighted individual score minus mean score, divided by the standard deviation. Scores were weighted for missing items only if missing items did not exceed 25%; scores with missing items >25% were excluded.
Vital Status
Information on vital status was obtained continuously via computerized linkages from municipal authorities. Mortality follow-up was 100% complete until October 2015.
Socio-demographic Age, sex, and educational level were considered potential confounders. Educational level was categorized as primary (primary only or unfinished secondary) or higher than primary education (secondary, vocational, or university).
Health-indicators Body mass index was calculated as weight in kilograms/height in meters 2 . Information on smoking habits was obtained during the home interview and participants were classified into never, past, and current smokers. Alcohol consumption was documented as ethanol per day in grams, calculated from available information (21) . Cognition was assessed by the Mini-Mental State examination (MMSE) (22) .
Prevalent disease and medication Hypertension was defined as systolic blood pressure ≥ 140 mmHg, or diastolic blood pressure ≥ 90 mmHg, or use of antihypertensive medication assessed by interview and pharmacy records (23) . Diabetes mellitus type 2 was diagnosed as fasting blood glucose ≥ 7.0 mmol/L or use of antidiabetic medication evaluated by interview and pharmacy records (24) . Previous stroke and myocardial infarction were determined by reported events on interview and confirmed by medical records (17) . Information on use of antidepressant medication was obtained by interview.
Dementia
Dementia was diagnosed according to DSM-III-R criteria for dementia, National Institute of Neurological and Communicable Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) for Alzheimer's disease (25) , and National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINCDS-AIREN) (26) criteria for vascular dementia following a standard protocol, and through continuous monitoring as described previously (27) .
Statistical Analyses
Trajectories of depressive symptoms
To identify trajectories of depressive symptoms over time, we used latent class trajectory modeling, which is a specialized form of finite mixture modeling designed to identify latent classes of individuals following similar progression of a determinant over time or with age (28, 29) . Using second-order polynomials, posterior probabilities for each trajectory were computed for every subject, taking into account their age (at the first round of depressive symptoms assessment 1993-1995), sex, and educational level. Subjects were then assigned to the trajectory with the highest probability. Criteria to determine the best-fitting number of trajectories included (i) minimum Bayesian Information Criterion (BIC) (29, 30) , (ii) maintaining a minimum posterior probability of .70 for class-membership, and (iii) class size (at least 2% of the population). To facilitate interpretability, we assigned labels to the identified trajectories based on their modeled graphical patterns (30) . We compared covariates across the observed trajectories using analysis of variance (ANOVA) for continuous and logistic regression for categorical variables.
Survival analyses
To compute hazard ratios for mortality across trajectories, we used Cox proportional hazards models. Adherence to proportional hazards assumption was assessed by plotting smoothed Schoenfeld residuals against time; no violations of the assumption were identified. We first calculated hazard ratios by trajectory for the entire follow-up period. Subsequently, we calculated hazard ratios using a cumulative follow-up time approach, that is, for shorter follow-up periods staring from 0 to 3 years and adding 3 years in every subsequent step. This was performed to investigate the pattern of survival across trajectories with increasing follow-up time. For all analyses, two models were fitted. Model 1 was adjusted for age and sex only; model 2 was additionally adjusted for educational level, body mass index, smoking, alcohol consumption, cognitive score, prevalent disease and events at baseline, including hypertension, diabetes mellitus, myocardial infarction, and stroke, and use of antidepressant medication.
The following variables had missing values that were dealt with using multiple imputations using all covariates of interest as predictors: education ( 
Sensitivity analysis
To investigate whether our findings were gender dependent, we tested the interaction between sex and depression trajectories. Furthermore, we calculated trajectories in men and women separately and calculated hazard ratios for mortality using these trajectories.
Although latent class modeling served as a useful data-reduction tool for understanding general patterns of depressive symptoms in our population, individual membership in a class or trajectory is probabilistic. To assess the robustness of trajectory classification and the associated risk of mortality across trajectories, and to check how mortality affects trajectory classification, we recalculated trajectories in a larger dataset including all participants (N = 5,300) with depressive symptoms data available at the three examination rounds (prevalent dementia cases excluded), that is, present in 1993-1995. This differs from the smaller main set of analyses in that it includes persons who died during the period of trajectory classification or were diagnosed of dementia during this period, that is, from 1993-1995 to [2002] [2003] [2004] . Of the 5300 participants, 1,734 died and 241 developed incident dementia (Supplementary Figure S2) . These numbers have some overlap, that is, 191 developed dementia and died (n = 191 + 1,543 = 1,734). However, if a person was diagnosed with dementia during the period of trajectory classification, we did not use their depressive symptom assessment score to calculate trajectories after they were diagnosed, due to the unreliability of scores. However, these persons remained in the analyses of trajectory calculation. This means that there were persons who were included with one depressive symptom assessment and then died, some who were included with two and then died, and others who were included with three depressive symptom assessments. We used this trajectory classification to investigate the subsequent 13 year risk of mortality as the main analysis, in the 3,325 participants who attended the examination round in [2002] [2003] [2004] . Notably, in both the main and sensitivity analyses, the survival analyses were performed in the same set of persons (N = 3,325). The difference was only the number of persons used for trajectory calculation. Importantly, we also explored the number of deaths which occurred during the period that defined the depressive symptom trajectories. This allowed us to explore which trajectory group suffered most deaths in the early follow-up.
All tests were 2-tailed and level of significance was set at 0.05. Analyses were performed using the Stata Software Version 13 (StataCorp, College Station, TX, USA).
Results
During the three examination rounds in 1993-1995, 1997-1999, and 2002-2004 , data for depressive symptoms were available for 2,821 (85%), 3,136 (94%), and 3,234 (97%) dementia-free participants, respectively. Of these, 3,325 had depressive symptoms assessment at least once, 3,254 (98%) at more than one examination rounds, and 2,612 (78.6%) at all three examination rounds. Mean age of the study population at the start of survival analysis (2002) (2003) (2004) ) was 75.6 ± 6.3 years and 60 % were women.
Trajectories of Depressive Symptoms
Using the latent-class trajectory modeling, five trajectories of depressive symptoms were identified (Figure 1 ), characterized by (i) very low depressive symptoms score throughout follow-up (T1: Low, n = 2,441, 73.4%), (ii) starting with moderate symptoms score but decreasing (T2: Decreasing, n = 369, 11.1%), (iii) starting low on depressive symptoms score, increasing but remitting later (T3: Remitting, n = 170, 5.1%), (iv) starting with a low depressive symptoms score but increasing steadily throughout follow-up (T4: Increasing, n = 255, 7.7%), and (v) maintaining a high score throughout (T5: High, n = 90, 2.7%). Mean depressive symptom scores and numbers of participants with clinically relevant depressive symptoms by trajectory at each visit are summarized in Supplementary Table S1 . Table 1 summarizes baseline characteristics of the study population. Compared with those in the low depressive symptoms trajectory, persons in the other trajectories were older and more probably women. Current smoking, alcohol consumption, and hypertension were more prevalent in individuals in the high and increasing depression trajectories. Mean probabilities per trajectory were universally high, ranging from 0.80 ± 0.18 to 0.94 ± 0.12 (Supplementary Table S2 ).
Survival Analyses
During 29,181.3 person-years, 1,631 (49%) participants died. Using the low symptoms trajectory as reference, a higher risk of mortality was observed only in the increasing trajectory over a maximum follow-up of 13.7 years in fully adjusted models, HR 1.21 (95% CI: 1.02, 1.44). Estimates for the high symptoms trajectory suggested a higher risk but not statistically significant, HR 1.20 (95% CI: 0.91, 1.58). The remitting trajectory high on depressive symptoms score at one time point was not associated with a higher risk of mortality compared with those with low symptoms, HR 1.06 (95% CI: 0.85, 1.32) ( Table 2 and Figure 2) . Table 3 shows hazard ratios for the cumulative follow-up periods by trajectory. In shorter follow-up periods, persons in the decreasing and remitting trajectories did not show an increased risk of mortality than those in the low trajectory, remitting trajectory 0-3 years (HR 0.94; 95% CI: 0.53, 1.66), 0-6 years (HR 0.99; 95% CI: 0.70, 1.41), 0-9 years (HR 1.02; 95% CI: 0.78, 1.34), and 0-12 years (HR 1.08; 95% CI: 0.86, 1.36). The increasing trajectory showed a 64% higher risk of dying in the first 3 years (HR 1.64; 95% CI: 1.15, 2.35), which gradually attenuated during follow-up. The high symptoms trajectory showed an almost twofold risk for the first 3 years of follow-up, attenuated slightly by adding follow-up years and remained significantly high till the first 9 years of follow-up (HR 1.38; 95% CI: 1.00, 1.89).
Sensitivity Analysis
We did not observe an interaction between depression trajectories and sex (p-value: .47).
In trajectories calculated separately in men (same patterns of trajectories obtained), compared with men with low or no symptoms (73.5%), those in the high symptoms trajectory (1.8%; HR 2.08 [95% CI: 1.30, 3.31]) and in the increasing trajectory (6.8%), (HR 1.37 [95% CI: 1.04, 1.80]) had a significantly higher risk of dying. Men in remitting (3.9%) and decreasing (13.9%) trajectories showed no risk.
In trajectories calculated separately in women (same patterns of trajectories obtained), compared with women with low or no symptoms (70.4%), only those in the increasing trajectory (8.3%), (HR 1.17 [95% CI: 1.01, 1.45]) had a higher risk of dying. Women in the high (2.6%), remitting (5.9%), and decreasing (12.8%) trajectories showed no higher risk of dying.
When trajectories of depressive symptoms were calculated including all participants with depressive symptoms data available for the three examination rounds, the identified trajectories were found to be largely similar to those in the main analyses. The subsequent pergroup risk of death using this trajectory classification also yielded a similar pattern of results as the main analyses (Supplementary  Table S3 ). Importantly, in this analysis, the mortality risk in both the high and the increasing trajectories was significantly higher than in the reference group, whereas the mortality risk of remitting groups was not. For this analysis, number of deaths per trajectory, which occurred before the survival analyses (before 2002-2004) , are shown in Supplementary Table S4 .
Discussion
This population-based prospective study of 3,325 older adults identified five distinct trajectories of depressive symptoms over 10 years characterized by low, decreasing, remitting, increasing, and high depressive symptoms. We found that risk of death was higher in persons with increasing or high depressive symptoms trajectories compared with those with low symptoms. In contrast, persons with decreasing or remitting depressive symptoms did not have a higher risk of death.
Previously, three patterns of depressive symptoms severity (persistent, high and declining symptoms, and low and declining symptoms) have been reported over a 12 month period in primary-care older adults; risk of death at 5 years was higher only in the persistent symptoms group (8) . Another study reported that chronic intermittent and chronic depression predicted excess mortality over 3.5 years, but transient depression did not (31) . However, a null association between depressive symptoms and mortality has also been reported in persons >70 years of age (32) . In our study, the trajectory with increasing depressive symptoms was associated with a higher mortality risk. This is in line with results from the Florida Retirement study; in this cohort, increasing depressive symptoms overtime were associated with a 57% higher risk of death (33) . In our study, estimates for the high depressive symptoms' trajectory were also suggestive of excess mortality. This suggests that increasing or chronically high symptoms predict mortality and not high symptoms at only one point in time. Although age, sex, current smoking, and comorbidities such as hypertension, diabetes, myocardial infarction, and stroke partly explained the excess mortality in increasing and high symptoms trajectories, fully adjusted results were still suggestive of a higher mortality in these trajectories. Although depression is more prevalent in women and possibly affects men and women differently (34), we did not see any significantly differential association in men and women in our study. Both the trajectory calculation and hazard ratios were adjusted for sex. Notably, use of antidepressants did not influence the association between depressive symptoms and mortality in our study. Although antidepressant medication is typically seen as a marker of more severe depression, this may be counterbalanced by the beneficial effect on morbidity and mortality. The estimates for the high trajectory were not statistically significant over 13.7 years of follow-up, which could be explained by insufficient power (n = 90). However, the pattern of results through the short follow-up periods clearly suggested a higher risk in this trajectory, as effect estimates were very strong in early years and were significant until 9 years of follow-up. In the last interval of stratified follow-up time, HR for the high trajectory was not significant, which is perhaps a lack of power as this trajectory suffered more deaths in the early years. In particular, in men the consistently high depressive symptoms showed a two-fold increased risk of death. In the absence of a formal sex difference in the association of trajectories with mortality, this has to be interpreted very carefully. The finding may however indicate that depression is more relevant to mortality in men or that the factors underlying this association differ between men and women.
In these trajectories, perhaps more subclinical physiologic mechanisms underlie the association with mortality rather than clinically apparent disorders. For example, the hypothalamic-pituitary axis, which is often hyperactive in depressed patients (35) , hyperactivity of the autonomic nervous system, and enhanced platelet aggregation in depressed patients are common causes of cardiovascular disease and thus may contribute to mortality (36, 37) . Also, lifestyle factors such as noncompliance to medication, unhealthy life-style with poor diet, or lack of exercise could underlie our observations. Interestingly, the remitting trajectory, although characterized by high depressive symptoms at one point, did not have excess mortality. A single and nonchronic episode of depressive symptoms was not associated with mortality. We can only speculate that high depressive symptoms in these persons indicated a "normal reaction" to life stressors such as grief or an episode of poor health. This result has clinical implications as it suggests that if depressive symptoms remit, at least some of the long-term health consequences probably attenuate. These results suggest that a remitting course of depressive symptoms has no worse survival implications than a trajectory characterized by few or no depressive symptoms. Repeated measures of depressive symptoms are certainly of value when predicting health outcomes or death. Hence, other studies observing a higher mortality risk associated with prevalent depression (12-16) might be underestimating the risk of those with more chronic depression, and at the same time over-estimating the risk for those with remitting symptoms.
The novelty of this study is the use of 23 years of follow-up data, identifying different trajectories of depressive symptoms over 10 years and investigating the subsequent long-term risk of death across these trajectories. By identifying high-risk groups from a population-based perspective, this approach might direct future etiological studies. Other strengths include a large population-based sample, a long and thorough mortality follow-up, and consideration of several potential confounders. In addition, using depressive symptoms as a continuum enabled measurement of subtle increases in the depression score. Although scarce, the available literature on the subject does indicate that different courses of depressive symptoms, particularly in clinical samples, are associated with different risks of dying. The course of depression in different populations is unique and the result of several risk and perpetuating factors; thus, studying depression in relation to long-term health outcomes should utilize the course of depression rather than rely on a single assessment. Studying different courses of depression rather than pooling the entire sample will prevent overlooking the subtle differences that determine the risk of death. However, there are some limitations to consider. We assessed depressive symptoms using two instruments, CESD and HADS in the first examination round (1993) (1994) (1995) . Although we standardized these depressive symptoms scores to combine them and make them more comparable, some difference in their distribution remained. However, this is unlikely to introduce bias as choice of depression screener was not related to participant characteristics. Our analyses were fit based on assigned trajectories and do not take into account the uncertainty in class-membership of each individual, which may mean that the variance estimates from our models are underestimated. However, plotting the universally high posterior probabilities of class-membership (mean = 0.88 ± 0.06, minimum = 0.80, maximum = 0.98) showed that it is unlikely that this would affect the general conclusions. In addition, because depression is related to a higher risk of death, participants with most severe depression may not be included in our analyses. This selection is probably strongest for the high trajectory in which 49.8% of participants died before the start of the survival analyses. Moreover, because the high depressive symptoms trajectory had fewer participants, a lack of power might explain why the estimates did not reach statistical significance. Moreover, some relevant characteristics, such as physical activity and social networking, were not measured in our study, which might have caused some residual confounding; future research trying to understand the observed trajectories and their relationship to mortality will benefit from looking further into such characteristics. Also, we excluded cases of dementia to ensure reliability of the depressive symptom scores. Therefore, we could not study course of depressive symptoms in patients with dementia who frequently have comorbid depression. Although we could model the course of depressive symptoms over a 12 year period, we did not have information on how depressed the participants were previously. Finally, this study was conducted in an urban setting and this might affect generalizability to other settings if different causes of depressive symptoms differentially affected mortality. Nonetheless, the current analyses represent an important first step toward describing the potential role of chronicity and late-life course of depressive symptoms in excess mortality. Future research may build upon these observed patterns to address refined etiological questions.
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